The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several ...

The American Hospital Association is calling on federal regulators to launch an antitrust investigation into its claims of drug manufacturers’ actions regarding 340B rebate models. In a letter sent to ...

AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B “rebate models.” ...

INDIANAPOLIS (Indiana Capital Chronicle) — A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

The 340B program is well-intentioned, but its design—funding institutions over patients—has led to widespread abuse and system manipulation.

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The 340B Drug Pricing Program is a vital lifeline for rural hospitals, but it needs responsible reform to preserve its original intent.

Validate that the pharmacy inventory management system is tracking 340B program drugs. Assess the organization’s utilization of GPOs in accordance with 340B program requirements.

The somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year.